100 related articles for article (PubMed ID: 28385455)
21. ACR Appropriateness Criteria® definitive external beam irradiation in stage T1 and T2 prostate cancer.
Moran BJ; DeRose P; Hsu IC; Abdel-Wahab M; Arterbery VE; Ciezki JP; Frank SJ; Mohler JL; Rosenthal SA; Rossi CJ; Yamada Y; Merrick GS
Am J Clin Oncol; 2011 Dec; 34(6):636-47. PubMed ID: 22101389
[TBL] [Abstract][Full Text] [Related]
22. Localised prostate cancer - current treatment options.
Duchesne G
Aust Fam Physician; 2011 Oct; 40(10):768-71. PubMed ID: 22003477
[TBL] [Abstract][Full Text] [Related]
23. Survival among men with clinically localized prostate cancer treated with radical prostatectomy or radiation therapy in the prostate specific antigen era.
Kibel AS; Ciezki JP; Klein EA; Reddy CA; Lubahn JD; Haslag-Minoff J; Deasy JO; Michalski JM; Kallogjeri D; Piccirillo JF; Rabah DM; Yu C; Kattan MW; Stephenson AJ
J Urol; 2012 Apr; 187(4):1259-65. PubMed ID: 22335870
[TBL] [Abstract][Full Text] [Related]
24. The Prostate Cancer Intervention Versus Observation Trial (PIVOT).
Wilt TJ; Brawer MK
Oncology (Williston Park); 1997 Aug; 11(8):1133-9; discussion 1139-40, 1143. PubMed ID: 9268976
[TBL] [Abstract][Full Text] [Related]
25. Correlation of [11C]choline PET-CT with time to treatment and disease-specific survival in men with recurrent prostate cancer after radical prostatectomy.
Breeuwsma AJ; Rybalov M; Leliveld AM; Pruim J; de Jong IJ
Q J Nucl Med Mol Imaging; 2012 Oct; 56(5):440-6. PubMed ID: 23069923
[TBL] [Abstract][Full Text] [Related]
26. Surgery or radiation: what is the optimal management for locally advanced prostate cancer?
Fletcher SG; Theodorescu D
Can J Urol; 2005 Feb; 12 Suppl 1():58-61; discussion 101-2. PubMed ID: 15780168
[TBL] [Abstract][Full Text] [Related]
27. 13-year outcomes following treatment for clinically localized prostate cancer in a population based cohort.
Albertsen PC; Hanley JA; Penson DF; Barrows G; Fine J
J Urol; 2007 Mar; 177(3):932-6. PubMed ID: 17296379
[TBL] [Abstract][Full Text] [Related]
28. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer.
Frank SJ; Pisters LL; Davis J; Lee AK; Bassett R; Kuban DA
J Urol; 2007 Jun; 177(6):2151-6; discussion 2156. PubMed ID: 17509305
[TBL] [Abstract][Full Text] [Related]
29. Prostate cancer outcomes of men with biopsy Gleason score 6 and 7 without cribriform or intraductal carcinoma.
Kweldam CF; Kümmerlin IP; Nieboer D; Verhoef EI; Steyerberg EW; Incrocci L; Bangma CH; van der Kwast TH; Roobol MJ; van Leenders GJ
Eur J Cancer; 2016 Oct; 66():26-33. PubMed ID: 27522247
[TBL] [Abstract][Full Text] [Related]
30. A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months.
Akakura K; Suzuki H; Ichikawa T; Fujimoto H; Maeda O; Usami M; Hirano D; Takimoto Y; Kamoto T; Ogawa O; Sumiyoshi Y; Shimazaki J; Kakizoe T;
Jpn J Clin Oncol; 2006 Dec; 36(12):789-93. PubMed ID: 17082219
[TBL] [Abstract][Full Text] [Related]
31. [Adjuvant medical treatment or radiotherapy following radical prostatectomy or curative radiotherapy].
Guy L
Bull Cancer; 2007 Jul; 94(7 Suppl):F15-20. PubMed ID: 17845989
[TBL] [Abstract][Full Text] [Related]
32. Study Protocol for the DETECTIVE Study: An International Collaborative Study To Develop Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer.
Lam TBL; MacLennan S; Plass K; Willemse PM; Mason MD; Cornford P; Donaldson J; Davis NF; Dell'Oglio P; Fankhauser C; Grivas N; Ingels A; Lardas M; Liew M; Pang KH; Paterson C; Omar MI; Zattoni F; Buddingh KT; Van den Broeck T; Cumberbatch MG; Fossati N; Gross T; Moris L; Schoots IG; van den Bergh RCN; Briers E; Fanti S; De Santis M; Gillessen S; Grummet JP; Henry AM; van der Poel HG; van der Kwast TH; Rouvière O; Tilki D; Wiegel T; N'Dow J; Van Poppel H; Mottet N
Eur Urol; 2019 Apr; 75(4):699-702. PubMed ID: 30473433
[No Abstract] [Full Text] [Related]
33. A novel randomised controlled trial design in prostate cancer.
Anastasiadis E; Ahmed HU; Relton C; Emberton M
BJU Int; 2015 Jul; 116(1):6-8. PubMed ID: 24628741
[No Abstract] [Full Text] [Related]
34. Are the National Institute for Health and Clinical Excellence guidelines that promulgate active surveillance for low-risk prostate cancer justified by the available evidence?
Parker C; Graham J
BJU Int; 2009 Feb; 103(4):554. PubMed ID: 19187350
[No Abstract] [Full Text] [Related]
35. Current state of the art, multimodality research and future visions for the treatment of patients with prostate cancer: consensus results from "Challenges and Chances in Prostate Cancer Research Meeting 2013".
Combs SE; Debus J; Feick G; Hadaschik B; Hohenfellner M; Schüle R; Zacharias JP; Schwardt M
Radiat Oncol; 2014 Nov; 9():224. PubMed ID: 25381175
[TBL] [Abstract][Full Text] [Related]
36. Evidence and efficacy: time to think beyond the traditional randomised controlled trial in patient safety studies.
Webster CS
Br J Anaesth; 2019 Jun; 122(6):723-725. PubMed ID: 30954239
[No Abstract] [Full Text] [Related]
37. Quality of evidence for treatment of prostate cancer.
Clarke M
JAMA; 2000 Oct; 284(14):1785-6. PubMed ID: 11025820
[No Abstract] [Full Text] [Related]
38. Localised prostate cancer: can we do better? There have been some advances in local control, but little impact on survival.
Prior T; Waxman J
BMJ; 2000 Jan; 320(7227):69-70. PubMed ID: 10625243
[No Abstract] [Full Text] [Related]
39. Methodological flaws in study on prostatic cancer.
Ekbom A; Taube A
Prostate; 1994 Jul; 25(1):53-6. PubMed ID: 8022711
[No Abstract] [Full Text] [Related]
40. Screening for prostate cancer. Randomised trials of treatment in early disease are important.
Harwood RH
BMJ; 1997 Jul; 315(7101):186-7. PubMed ID: 9251560
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
